Jan 11
New meds they put me on got me feeling like I got dosed with dizzy pills
seen from France
seen from Canada
seen from United States
seen from United States
seen from Estonia
seen from United States
seen from Malaysia
seen from Canada
seen from United States
seen from Brazil
seen from United States
seen from Türkiye
seen from United Kingdom
seen from United States
seen from United States
seen from United Kingdom
seen from Brazil
seen from Türkiye
seen from China
seen from Malaysia
New meds they put me on got me feeling like I got dosed with dizzy pills
If this isn’t the truth! Zonisomide was making me have tonic-colonic seizures. Now that I’m off, I haven’t had one since. Medication making life hell…
Epilepsy culture is having to deal with not just the aftermath of seizures, but the side effects of meds. And no one really takes your suffering seriously because “your seizures aren’t common so it can’t affect you THAT much”
Also ✨chronic tiredness✨👌
and the withdrawal when you can't get a refill of your prescription in time :)
Brexit contingency plans for epilepsy medication
In August 2018, the Government asked pharmaceutical companies to ensure they have a minimum six week stockpile of prescription-only and pharmacy-only medicines in case of potential delays at UK borders after Brexit on 31 October 2019.
We have contacted pharmaceutical companies in the UK to find out what their individual contingency plans are. Their responses are detailed in the table below.
Epilepsy Society's Medical Director, Professor Ley Sander has also advised people with epilepsy not to stockpile medication themselves.
"There is a lot of anxiety about supply of medication post Brexit and some people are finding ways to try to stockpile medicines themselves," he said.
"We understand people's concerns, however this has the potential to create a shortage of medication itself. It is important for everyone to stay calm and follow their normal routine when it comes to getting a repeat prescription.
"The contingency plans put in place by the Department of Health and Social Care are the most effective way to ensure that everyone has a consistent supply of their medication."
Serious shortage protocol
The Government has also confirmed that epilepsy medicines will be exempt from its serious shortage protocol. This will give pharmacists power to dispense alternative drugs if those prescribed by GPs are in short supply at any time, including during the possibility of a 'no-deal Brexit' scenario after Britain leaves the EU.
If there is a shortage of a particular epilepsy medication, clinicians would advise the most appropriate course of action. Where necessary, the Department of Health and Social Care would seek to access the medication from an alternative source.
Find out more below on Brexit contingency plans for epilepsy medications from pharmaceutical companies.
Lamictal (lamotrigine) dispersible tablets
Company: Glaxo-Smith Kline (GSK)
Dosage: 2mg, 5mg, 25mg and 100mg
Contingency Plan:
Update 23/9/19: "Throughout the Brexit process, GSK’s priority has been to maintain the continuity of supply of medicines, vaccines and healthcare products for patients and consumers. To minimise the potential for disruption to supply when the UK exits the EU, we started preparing for Brexit immediately following the referendum result. We took a risk-based approach to mitigation, preparing for all scenarios including no deal.
The bulk of our new post-Brexit operating model is now in place, and arrangements linked to customs and borders are ready to be implemented as the UK leaves the EU. There is a fair amount of detail outlined in our annual report (p36) on the specific activities we undertook, including expanding our ability to conduct re-testing and certification of medicines, amending manufacturing and importation licences, updating packaging, securing additional warehousing and transferring Marketing Authorisation Holders to EU regulators for EU supply. Our operating model includes robust forecasting, control of our stock and additional warehouse capacity in the UK. We have adjusted safety stock levels and identified alternative transportation routes that avoid the busy short straits crossing between the UK and EU, which we’ll utilise to mitigate for potential disruption at the EU/UK borders around Brexit date.
Supply continuity has been and continues to be our overriding priority and we are confident we have done everything in our control to prepare for Brexit. Our plans are being kept under constant review, including at an individual product level, as the Brexit process continues. We have extensive experience managing our complex supply chains and we are taking mitigating action around products that may be affected. Where we anticipate issues, we will inform the regulator at the earliest opportunity."
Below is the response to the first Brexit date of 29 March 2019:
"Until there is formal agreement, we will continue to implement our contingency plans for all scenarios, including no deal."
Lamictal (lamotrigine) tablets
Company: Glaxo-Smith Kline (GSK)
Dosage: 25mg, 50mg, 100mg and 200mg
Contingency Plan:
Update 23/9/19: "Throughout the Brexit process, GSK’s priority has been to maintain the continuity of supply of medicines, vaccines and healthcare products for patients and consumers. To minimise the potential for disruption to supply when the UK exits the EU, we started preparing for Brexit immediately following the referendum result. We took a risk-based approach to mitigation, preparing for all scenarios including no deal.
The bulk of our new post-Brexit operating model is now in place, and arrangements linked to customs and borders are ready to be implemented as the UK leaves the EU. There is a fair amount of detail outlined in our annual report (p36) on the specific activities we undertook, including expanding our ability to conduct re-testing and certification of medicines, amending manufacturing and importation licences, updating packaging, securing additional warehousing and transferring Marketing Authorisation Holders to EU regulators for EU supply. Our operating model includes robust forecasting, control of our stock and additional warehouse capacity in the UK. We have adjusted safety stock levels and identified alternative transportation routes that avoid the busy short straits crossing between the UK and EU, which we’ll utilise to mitigate for potential disruption at the EU/UK borders around Brexit date.
Supply continuity has been and continues to be our overriding priority and we are confident we have done everything in our control to prepare for Brexit. Our plans are being kept under constant review, including at an individual product level, as the Brexit process continues. We have extensive experience managing our complex supply chains and we are taking mitigating action around products that may be affected. Where we anticipate issues, we will inform the regulator at the earliest opportunity."
Below is the response to the first Brexit date of 29 March 2019:
"Until there is formal agreement, we will continue to implement our contingency plans for all scenarios, including no deal."
Does Aiden take seizure medication?
He does - although his doctor wants to wean him off them because it’s been so long since he had his last seizure, but Aiden is reluctant to because he knows if he has another:1) he won’t be allowed to drive until he’s seizure free for a year;2) he could risk his nursing career.
A reduction in Declan Horton's medication was a "considerable" factor in his death, a coroner finds.
Neurology Medicine: Are These the Right Choices?
When treating neurological disorders, selecting the right medicine can make all the difference in managing symptoms and improving the quality of life. Neurology medicine, which covers treatments for diseases affecting the brain, spine, and nervous system, is critical in today’s healthcare landscape. In this blog post, we will explore the essential medicines included in a neurology medicine list and how Biovatic LifeScience, a leading Indian medical company, contributes to this field.
What is Neurology Medicine?
Neurology medicine refers to treating disorders related to the nervous system, including the brain, spinal cord, and nerves. Neurological disorders can range from common conditions like migraines and epilepsy to complex diseases like Parkinson's disease and multiple sclerosis.
Doctors use a variety of medications to treat these disorders. The right neurology medicines can help control symptoms, prevent further damage, and improve patients' overall well-being.
Common Neurological Disorders and the Role of Medicine
Here’s a quick look at some common neurological conditions and how medicine plays a role in their treatment:
EpilepsyEpilepsy is a condition that causes recurring seizures. Medications like antiepileptics (e.g., levetiracetam, phenytoin) help control these seizures.
Parkinson’s DiseaseParkinson's disease affects movement and can cause tremors, stiffness, and balance problems. Medications such as levodopa and dopamine agonists are used to manage symptoms.
Multiple SclerosisMultiple sclerosis affects the brain and spinal cord, leading to a wide range of symptoms. Disease-modifying treatments (DMTs) are used to slow disease progression.
Alzheimer’s DiseaseAlzheimer’s disease is a type of dementia that causes memory loss and cognitive decline. Drugs like donepezil and rivastigmine are used to manage symptoms, though there is currently no cure.
MigraineMigraine is a common neurological condition that causes severe headaches. Medications like triptans, beta-blockers, and anti-inflammatory drugs help manage migraine attacks.
Neurology Medicine List: What Should It Include?
A neurology medicine list includes essential drugs used to treat a variety of neurological conditions. The right medication depends on the specific disorder and the patient's needs. Some of the key categories of neurology medications are:
Antiepileptics (AEDs): Used for epilepsy and seizure disorders.
Antiparkinson Drugs: These include dopamine agonists, MAO-B inhibitors, and levodopa.
Disease-Modifying Therapies (DMTs): Used for conditions like multiple sclerosis.
Cognitive Enhancers: Drugs such as acetylcholinesterase inhibitors help with cognitive decline in Alzheimer’s disease.
Pain Management Drugs: For conditions like migraine or trigeminal neuralgia, pain management plays a crucial role.
How Biovatic LifeScience Contributes to Neurology Medicine
Biovatic LifeScience, a prominent Jaipur medical company, is at the forefront of providing high-quality neurological medications to improve patient care. Their commitment to innovation, research, and accessibility ensures that patients with neurological disorders receive the best possible treatment.
Biovatic LifeScience’s extensive neurology medicine list includes various products designed to meet the needs of patients with a wide range of neurological conditions. The company ensures that all its medicines are rigorously tested for safety and efficacy, allowing healthcare providers to offer the most effective treatments to patients.
Choosing the Right Neurology Medicine
With so many treatment options available, choosing the right neurology medicine can be overwhelming. It's important to work closely with a healthcare provider who understands the nuances of the patient’s condition. They will consider factors like:
The severity of the condition
The patient's age and overall health
The potential side effects of the medication
The patient’s response to previous treatments
FAQs About Neurology Medicine
1. What are the main types of neurology medicines?Neurology medicines typically fall into categories like antiepileptics, antiparkinson drugs, disease-modifying therapies, cognitive enhancers, and pain management drugs.
2. How do I know which medication is right for me?Consulting with a neurologist is essential. They will consider your specific symptoms, medical history, and other factors to prescribe the most appropriate treatment.
3. Can neurological medications cure conditions?While many neurological medications can help manage symptoms and slow disease progression, most neurological conditions cannot be fully cured. Medications focus on symptom management and improving quality of life.
4. Are there any side effects of neurology medicines?Like all medications, neurology medicines can have side effects. These vary depending on the specific drug, and your doctor will help you manage any side effects that arise.
5. What makes Biovatic LifeScience different in providing neurology medicine?Biovatic LifeScience stands out because of its commitment to innovation, safety, and quality. The company works tirelessly to develop and distribute effective neurology medicines that meet international standards.
Conclusion
Neurology medicines play an important role in managing and treating a variety of neurological disorders. From epilepsy and Parkinson’s disease to Alzheimer’s and migraines, these medications help improve patient outcomes and quality of life. Biovatic LifeScience’s dedication to providing high-quality, reliable medicines makes it a trusted partner in the healthcare industry, particularly for those in need of neurological treatments.
If you or a loved one is dealing with a neurological disorder, consulting with a medical professional and considering a comprehensive neurology medicine list is an essential step toward managing the condition effectively. With the right treatments, you can take control of your neurological health and lead a better, more fulfilling life. Contact us
Advancements of Epilepsy Treatment and Surgery!